Kodiak Sciences (KOD) Non-Current Assets (2017 - 2026)
Kodiak Sciences (KOD) posted Non-Current Assets of $130.7 million for Q1 2026, down 4.37% on a QoQ basis from $136.7 million in Q4 2025, and down 15.77% year-over-year from $155.2 million in Q1 2025.
Kodiak Sciences (KOD) Non-Current Assets (2017 - 2026) Analysis & Trends
Kodiak Sciences' Non-Current Assets history runs 10 years deep, the most recent figure standing at $130.7 million for Q1 2026.
- Quarterly Non-Current Assets fell 15.77% year-over-year to $130.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $558.6 million (down 16.12% YoY) and the FY2025 annual result came in at $136.7 million, down 16.45% from the prior year.
- Non-Current Assets was $130.7 million for Q1 2026 at Kodiak Sciences, down from $136.7 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $209.2 million in Q1 2023 and bottomed at $130.7 million in Q1 2026.
- A 5-year average of $171.3 million and a median of $177.0 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 66.71% — and 2025, when it decreased 16.45%.
- Kodiak Sciences' Non-Current Assets stood at $180.6 million in 2022, then advanced by 5.23% to $190.1 million in 2023, then dropped by 13.9% to $163.6 million in 2024, then retreated by 16.45% to $136.7 million in 2025, then fell by 4.37% to $130.7 million in 2026.
- Business Quant data shows KOD's Non-Current Assets at $130.7 million in Q1 2026, $136.7 million in Q4 2025, and $142.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | 130.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 130.75 Mn |
| Dec 31, 2025 | 136.72 Mn |
| Sep 30, 2025 | 142.34 Mn |
| Jun 30, 2025 | 148.81 Mn |
| Mar 31, 2025 | 155.22 Mn |
| Dec 31, 2024 | 163.64 Mn |
| Sep 30, 2024 | 170.18 Mn |
| Jun 30, 2024 | 176.95 Mn |
| Mar 31, 2024 | 183.25 Mn |
| Dec 31, 2023 | 190.06 Mn |
| Sep 30, 2023 | 196.73 Mn |
| Jun 30, 2023 | 202.70 Mn |
| Mar 31, 2023 | 209.22 Mn |
| Dec 31, 2022 | 180.62 Mn |
| Sep 30, 2022 | 179.33 Mn |
| Jun 30, 2022 | 177.54 Mn |
| Mar 31, 2022 | 168.10 Mn |
| Dec 31, 2021 | 169.41 Mn |
| Sep 30, 2021 | 152.70 Mn |
| Jun 30, 2021 | 113.27 Mn |